Navigation Links
MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
Date:4/7/2008

ines. The company applies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late stage development for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' pipeline also includes a drug candidate in early clinical development for the treatment of asthma and chronic obstructive pulmonary disease.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to the further development of MAP0005 and the potential application of MAP Pharmaceuticals' technologies to additional product candidates. Actual results may differ materially from current expectations based on risks and uncertainties affecting the Company's business, including, without limitation, risks and uncertainties relating to the development and commercialization of product candidates incorporating MAP Pharmaceuticals' technologies. The reader is cautioned not to unduly rely on the forward- looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Annual Report on Form 10K, filed with the SEC on March 20, 2008, available at http://edgar.sec.gov.


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
2. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
3. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
4. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
5. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
6. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
7. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
8. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
9. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
10. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
11. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ReportsnReports.com adds Global Medical ... forecasts as well as Global Medical Simulation Market ... collection of its library. Complete 2015 ... spread across 164 pages, talking about 7 major ... is now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html . ...
(Date:8/3/2015)... , Aug. 3, 2015 OmniSeq, LLC ... Institute to the OmniSeq SM Genomic Network.  ... Cancer Institute (RPCI) and announced it was making ... a physician-driven, collaborative approach to genomic diagnostics that ... Cancer Institute is a rapidly expanding, multidisciplinary cancer ...
(Date:8/3/2015)... Aug. 3, 2015 Ortho Clinical Diagnostics (OCD) ... named Chief Corporate Brand and Communications Officer, effective immediately. ... team, Bouryal will lead the company,s worldwide corporate brand ... transition to an independent company by adding sites in ... and Chief Executive Officer Dr. Martin Madaus . ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2
(Date:8/4/2015)... ... August 04, 2015 , ... Many men are confused ... subject, Renew Man™ is standing up as a voice of authority for men seeking ... healthy aging industry with special experience and expertise in the safe and effective treatment ...
(Date:8/4/2015)... ... 2015 , ... Buckeye Health Plan is reminding parents to ... covered for members under the Healthchek program . , “Many schools have ... immunizations may not be allowed to attend when school begins in August,” said ...
(Date:8/4/2015)... ... August 04, 2015 , ... SanusEO, the healthcare industry innovator ... executive leadership team as Senior Vice President of Sales and Marketing. Mr. McCalley ... global markets with a special emphasis on the healthcare industry. , Today, patients ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... T.E.N., an ... for vendor participating in The ISE® Lions’ Den and Jungle Lounge 2015, which will ... in Las Vegas. , During the event, eight emerging security vendors, known as “Gazelles,” ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... finds the North America IT reseller channel will grow at least 6 percent ... of their 2014 pace and greater than their OEM/vendor partners. , The ...
Breaking Medicine News(10 mins):Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... Merck is in trouble again. The Federal Drug Administration of U.S ... was pulled out of the market due to safety reasons. ... same class of drugs as Vioxx ,was voted out 20-1 ... Vioxx from the market in September 2004 after research showed that ...
... can be increasingly used to improve patient care. In a recent ... around 2,250 babies in US alone who succumb to sudden infant ... assistant at the University of Texas has come up with a ... , ,Hung Cao, along with his friends developed a device ...
... Fiorillo noticed that her daughter Bianca could not seem to ... She seemed slower at doing things compared to the other ... on diagnoses it was found that she has CMT, Charcot-Marie-Tooth ... and her brother Tony too suffered from it. ...
... therapy for coronary artery disease is four times more likely ... same medical history. ,Historically, studies have shown ... men, but it has remained unclear how much less effective ... pharmacist and adjunct clinical instructor at the University of Michigan ...
... A former official of the Mets, a leading baseball team ... federal court in San Francisco to distributing// performance-enhancing drugs to ... a decade. ,Kirk Radomski, 37, who had worked ... admitted to selling banned drugs, including anabolic steroids, amphetamines and ...
... may be as important to your health as the food ... toxins that might soon become// as important a risk factor ... ,This class of toxins, called advanced glycation end ... of grilled, fried, or broiled animal products, such as meats ...
Cached Medicine News:Health News:Arcoxia Slammed –Nothing Better Than Vioxx Says FD 2Health News:RFID Use can Avoid Sudden Infant Death Syndrome 2Health News:Cure for CMT 2Health News:Aspirin Therapy for Heart Disease Found More Effective for Men Than Women 2Health News:Aspirin Therapy for Heart Disease Found More Effective for Men Than Women 3Health News:Former Official Confesses He Had Sold Steroids to Leading Baseball Players 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 3Health News:Food Preparation may Play a Bigger Role in Chronic Disease 4
... adjusted for perfect focus where it's needed ... This, along with Keeler's wide angle light ... the patient's pupil size, you will see ... Lithium-ion technology provides a longer life battery ...
... ophthalmoscopes are individually adjusted for perfect focus ... not on paper. This, along with Keeler's ... ensures that whatever the patient's pupil size, ... field of view. Lithium-ion technology provides a ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
A full function instrument at an economical price....
Medicine Products: